Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v8-EN
Language English English
Date Updated 2020-02-27 2020-02-27
Drug Identification Number 02428210 02428210
Brand name LAMOTRIGINE LAMOTRIGINE
Common or Proper name LAMOTRIGINE LAMOTRIGINE
Company Name SIVEM PHARMACEUTICALS ULC SIVEM PHARMACEUTICALS ULC
Ingredients LAMOTRIGINE LAMOTRIGINE
Strength(s) 100MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-12-24 2019-12-24
Actual start date 2019-12-23 2019-12-23
Estimated end date Unknown Unknown
Actual end date 2020-02-26 2020-02-26
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments